What sets OcuTap apart:
Over 40% of ocular inflammation cases are linked to viral infections, many of which go undetected. Without timely treatment, these infections can lead to early cataracts, scar tissue, chronic retinal swelling, and even permanent vision loss from glaucoma.
OcuTap’s innovative technology helps detect and treat these infections early, reducing complications, improving treatment outcomes, and lowering the costs associated with improper management.
Current standard of care
OcuTap device
Traditional eye fluid collection uses a 30-gauge needle and a 1-mL syringe, requiring extreme precision to avoid complications like iris bleeding or vision loss. The needle is inserted between the cornea and sclera to access the aqueous humor, a critical step in diagnosing infections and other eye conditions.
Meet OcuTap: a revolutionary tool for ocular biopsy. Designed for ease and safety, OcuTap features a custom needle and collection chamber for one-handed operation. This innovation enhances patient safety, improves testing accuracy, and streamlines fluid collection, significantly reducing the risk of complications.
Our novel technology has several key differentiators that set it apart from the current standard of care.
Enhances physician control and ensures a safer procedure
A vacuum system prevents fluid retention in the needle hub or flow path
Button actuation provides precise control over fluid flow and withdrawal
Eliminates transfer steps, simplifies the process, and prepares samples directly for shipping
OcuTap is designed with both the user and patient in mind. Its ergonomic, one-handed operation simplifies fluid collection and streamlines sample preparation for shipping, reducing the risk of fluid loss and saving valuable time.